<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02996253</url>
  </required_header>
  <id_info>
    <org_study_id>2015/16389</org_study_id>
    <nct_id>NCT02996253</nct_id>
  </id_info>
  <brief_title>Endoscopic Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture</brief_title>
  <official_title>Endoscopic Assisted Transfer of Flexor Hallucis Longus Tendon for Chronic Achilles Tendon Rupture. A Prospective Multi Center Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Hospital, Fredrikstad</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The transfer of Flexor Hallucis Longus (FHL) in the management of chronic Achilles tendon
      ruptures has demonstrated good functional outcome, but an extensive surgical field at a
      vulnerable location may lead to increased risk for soft tissue problems. The arthroscopic FHL
      transfer may reduce the risk for soft tissue problems. Functional outcome parameters are
      investigated, wound/soft tissue complications registered.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The transfer of FHL in the management of chronic Achilles tendon ruptures has demonstrated
      good functional outcome with American Orthopaedic Foot ane Ankle Society (AOFAS) hindfoot
      scores at 80-89. The extensive surgical field by either a two-incision approach or a single
      longitudinal posterior approach to the Achilles tendon may lead to an increased risk for soft
      tissue problems, both infections and wound healing problems. The endoscopic FHL transfer may
      reduce the risk for soft tissue problems while retaining a good functional outcome. Several
      functional outcome measures and scores are evaluated a year after surgery.

      Prospective study for evaluation of the surgical procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Victorian Institute of Sports Assessment- Achilles Questionnaire (VISA-A) outcome score</measure>
    <time_frame>one year after FHL transfer</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale for Pain (VAS pain) score</measure>
    <time_frame>3, 6 and 12 months after FHL transfer</time_frame>
    <description>patient reported outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient reported function score (PRFS)</measure>
    <time_frame>6, 12 months</time_frame>
    <description>patient reported Activity related disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnetic resonance imagine (MRI)</measure>
    <time_frame>one year post surgery</time_frame>
    <description>FHL hypertrophy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional test battery</measure>
    <time_frame>12 months</time_frame>
    <description>jump- and strength tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local wound conditions</measure>
    <time_frame>within 12 weeks</time_frame>
    <description>wound infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AOFAS hindfoot</measure>
    <time_frame>3,6,12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VISA-A</measure>
    <time_frame>6 months after surgery</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Achilles Tendon Rupture</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FHL transfer</intervention_name>
    <description>endoscopic transfer og flexor hallucis longus</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients With chronic Achilles Tendon Rupture
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Achilles Tendon Rupture

        Exclusion Criteria:

          -  Pregnancy

          -  BMI&lt;18.5 or &gt;39.9

          -  Insufficient Norwegian Language proficiency lack of communication skills local skin
             conditions at site for planned surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth E Husebye, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth E Husebye, MD, PhD</last_name>
    <phone>0047 95133773</phone>
    <email>i.e.e.husebye@medisin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Are H Stoedle, MD</last_name>
    <phone>0047 97174507</phone>
    <email>arhauk@us-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0450</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth E Husebye, MD, PhD</last_name>
      <phone>0047 95133773</phone>
      <email>i.e.e.husebye@medisin.uio.no</email>
    </contact>
    <contact_backup>
      <last_name>Are H Stoedle, MD</last_name>
      <phone>0047 97174507</phone>
      <email>arhauk@ous-hf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Elisabeth E Husebye, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2016</study_first_submitted>
  <study_first_submitted_qc>December 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2016</study_first_posted>
  <last_update_submitted>December 19, 2016</last_update_submitted>
  <last_update_submitted_qc>December 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Elisabeth Ellingsen Husebye</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

